Effects of incarceration on HIV-infected individuals

Moya M. Griffin, John Ryan, Victoria S. Briscoe, Kathleen M. Shadle

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Human immunodeficiency virus (HIV) infection is a critical problem among the incarcerated population, with rates as high as 17% being reported for prison systems in New York. The literature suggests that stressful living conditions and inherent defects in the immune system associated with HIV infection make prison populations more susceptible to a disproportionate decrease in their CD4 counts. To determine the effects of incarceration on HIV-infected individuals, the charts of 800 inmates were reviewed. Baseline (draw 1), 2- to 5-month (draw 2), and 6- to 12-month (draw 3) CD4 cell counts were obtained. Mean cell counts were calculated, and paired t-tests were used to identify differences. The group receiving antiretrovirals throughout showed no difference in mean CD4 cell count between draws 1 and 2 or between draws 1 and 3. The group not receiving HIV medications did not show a significant difference in CD4 cell counts between draws 1 and 2, but did show a significant difference between draws 1 and 3. For this group, the rate of decline in CD4 cells was greater than among an outpatient setting. The subsample of subjects initiating therapy prior to the second blood draw showed a significant increase in mean CD4 cell counts at draw 1 versus draw 2, but did not show a significant change when comparing draw 1 to draw 3. When examining subjects based on their antiviral status, the mean CD4 cell count at each of the draws was statistically associated with subjects' antiviral status. We conclude that incarceration causes a more rapid decrease in CD4 cells compared with an outpatient population, causing clinical significance on the normal course of HIV disease.

Original languageEnglish
Pages (from-to)639-644
Number of pages6
JournalJournal of the National Medical Association
Volume88
Issue number10
StatePublished - Oct 1 1996
Externally publishedYes

Fingerprint

CD4 Lymphocyte Count
HIV
Virus Diseases
Prisons
Antiviral Agents
Outpatients
Population
Social Conditions
Immune System
Cell Count

Keywords

  • Human immunodeficiency virus (HIV)
  • Incarceration
  • Pharmaceutical intervention

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Griffin, M. M., Ryan, J., Briscoe, V. S., & Shadle, K. M. (1996). Effects of incarceration on HIV-infected individuals. Journal of the National Medical Association, 88(10), 639-644.

Effects of incarceration on HIV-infected individuals. / Griffin, Moya M.; Ryan, John; Briscoe, Victoria S.; Shadle, Kathleen M.

In: Journal of the National Medical Association, Vol. 88, No. 10, 01.10.1996, p. 639-644.

Research output: Contribution to journalArticle

Griffin, MM, Ryan, J, Briscoe, VS & Shadle, KM 1996, 'Effects of incarceration on HIV-infected individuals', Journal of the National Medical Association, vol. 88, no. 10, pp. 639-644.
Griffin, Moya M. ; Ryan, John ; Briscoe, Victoria S. ; Shadle, Kathleen M. / Effects of incarceration on HIV-infected individuals. In: Journal of the National Medical Association. 1996 ; Vol. 88, No. 10. pp. 639-644.
@article{3b8af58ef19445e4b662d2748d7c8afc,
title = "Effects of incarceration on HIV-infected individuals",
abstract = "Human immunodeficiency virus (HIV) infection is a critical problem among the incarcerated population, with rates as high as 17{\%} being reported for prison systems in New York. The literature suggests that stressful living conditions and inherent defects in the immune system associated with HIV infection make prison populations more susceptible to a disproportionate decrease in their CD4 counts. To determine the effects of incarceration on HIV-infected individuals, the charts of 800 inmates were reviewed. Baseline (draw 1), 2- to 5-month (draw 2), and 6- to 12-month (draw 3) CD4 cell counts were obtained. Mean cell counts were calculated, and paired t-tests were used to identify differences. The group receiving antiretrovirals throughout showed no difference in mean CD4 cell count between draws 1 and 2 or between draws 1 and 3. The group not receiving HIV medications did not show a significant difference in CD4 cell counts between draws 1 and 2, but did show a significant difference between draws 1 and 3. For this group, the rate of decline in CD4 cells was greater than among an outpatient setting. The subsample of subjects initiating therapy prior to the second blood draw showed a significant increase in mean CD4 cell counts at draw 1 versus draw 2, but did not show a significant change when comparing draw 1 to draw 3. When examining subjects based on their antiviral status, the mean CD4 cell count at each of the draws was statistically associated with subjects' antiviral status. We conclude that incarceration causes a more rapid decrease in CD4 cells compared with an outpatient population, causing clinical significance on the normal course of HIV disease.",
keywords = "Human immunodeficiency virus (HIV), Incarceration, Pharmaceutical intervention",
author = "Griffin, {Moya M.} and John Ryan and Briscoe, {Victoria S.} and Shadle, {Kathleen M.}",
year = "1996",
month = "10",
day = "1",
language = "English",
volume = "88",
pages = "639--644",
journal = "Journal of the National Medical Association",
issn = "1943-4693",
publisher = "National Medical Association",
number = "10",

}

TY - JOUR

T1 - Effects of incarceration on HIV-infected individuals

AU - Griffin, Moya M.

AU - Ryan, John

AU - Briscoe, Victoria S.

AU - Shadle, Kathleen M.

PY - 1996/10/1

Y1 - 1996/10/1

N2 - Human immunodeficiency virus (HIV) infection is a critical problem among the incarcerated population, with rates as high as 17% being reported for prison systems in New York. The literature suggests that stressful living conditions and inherent defects in the immune system associated with HIV infection make prison populations more susceptible to a disproportionate decrease in their CD4 counts. To determine the effects of incarceration on HIV-infected individuals, the charts of 800 inmates were reviewed. Baseline (draw 1), 2- to 5-month (draw 2), and 6- to 12-month (draw 3) CD4 cell counts were obtained. Mean cell counts were calculated, and paired t-tests were used to identify differences. The group receiving antiretrovirals throughout showed no difference in mean CD4 cell count between draws 1 and 2 or between draws 1 and 3. The group not receiving HIV medications did not show a significant difference in CD4 cell counts between draws 1 and 2, but did show a significant difference between draws 1 and 3. For this group, the rate of decline in CD4 cells was greater than among an outpatient setting. The subsample of subjects initiating therapy prior to the second blood draw showed a significant increase in mean CD4 cell counts at draw 1 versus draw 2, but did not show a significant change when comparing draw 1 to draw 3. When examining subjects based on their antiviral status, the mean CD4 cell count at each of the draws was statistically associated with subjects' antiviral status. We conclude that incarceration causes a more rapid decrease in CD4 cells compared with an outpatient population, causing clinical significance on the normal course of HIV disease.

AB - Human immunodeficiency virus (HIV) infection is a critical problem among the incarcerated population, with rates as high as 17% being reported for prison systems in New York. The literature suggests that stressful living conditions and inherent defects in the immune system associated with HIV infection make prison populations more susceptible to a disproportionate decrease in their CD4 counts. To determine the effects of incarceration on HIV-infected individuals, the charts of 800 inmates were reviewed. Baseline (draw 1), 2- to 5-month (draw 2), and 6- to 12-month (draw 3) CD4 cell counts were obtained. Mean cell counts were calculated, and paired t-tests were used to identify differences. The group receiving antiretrovirals throughout showed no difference in mean CD4 cell count between draws 1 and 2 or between draws 1 and 3. The group not receiving HIV medications did not show a significant difference in CD4 cell counts between draws 1 and 2, but did show a significant difference between draws 1 and 3. For this group, the rate of decline in CD4 cells was greater than among an outpatient setting. The subsample of subjects initiating therapy prior to the second blood draw showed a significant increase in mean CD4 cell counts at draw 1 versus draw 2, but did not show a significant change when comparing draw 1 to draw 3. When examining subjects based on their antiviral status, the mean CD4 cell count at each of the draws was statistically associated with subjects' antiviral status. We conclude that incarceration causes a more rapid decrease in CD4 cells compared with an outpatient population, causing clinical significance on the normal course of HIV disease.

KW - Human immunodeficiency virus (HIV)

KW - Incarceration

KW - Pharmaceutical intervention

UR - http://www.scopus.com/inward/record.url?scp=0030266439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030266439&partnerID=8YFLogxK

M3 - Article

C2 - 8918068

AN - SCOPUS:0030266439

VL - 88

SP - 639

EP - 644

JO - Journal of the National Medical Association

JF - Journal of the National Medical Association

SN - 1943-4693

IS - 10

ER -